ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $36,994,000 | +5689.4% | 214,959 | +4121.5% | 0.13% | +4333.3% |
Q2 2021 | $639,000 | +161.9% | 5,092 | +182.9% | 0.00% | +50.0% |
Q1 2021 | $244,000 | -39.5% | 1,800 | -42.9% | 0.00% | 0.0% |
Q4 2020 | $403,000 | -88.9% | 3,155 | -90.2% | 0.00% | -90.0% |
Q3 2020 | $3,624,000 | +377.5% | 32,200 | +304.3% | 0.02% | +300.0% |
Q2 2020 | $759,000 | +94.6% | 7,965 | +83.8% | 0.01% | +150.0% |
Q1 2020 | $390,000 | +27.0% | 4,334 | -25.3% | 0.00% | 0.0% |
Q4 2019 | $307,000 | +29.0% | 5,800 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $238,000 | -67.4% | 5,800 | -63.1% | 0.00% | -60.0% |
Q1 2019 | $731,000 | +28.9% | 15,713 | +20.7% | 0.01% | +25.0% |
Q4 2018 | $567,000 | -58.4% | 13,016 | -45.3% | 0.00% | -50.0% |
Q3 2018 | $1,362,000 | +274.2% | 23,800 | +155.9% | 0.01% | +300.0% |
Q1 2018 | $364,000 | -79.9% | 9,300 | -78.3% | 0.00% | -77.8% |
Q4 2017 | $1,815,000 | – | 42,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |